Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial

Although genetics is a relevant risk factor in acute myeloid leukemia (AML), it can be minimally informative and/or not readily available for the early identification of patients at risk for treatment failure. In a randomized trial comparing standard vs high-dose induction (ClinicalTrials.gov #NCT00...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Gianfaldoni, Giacomo, Mannelli, Francesco, Intermesoli, Tamara, Bencini, Sara, Giupponi, Damiano, Farina, Giorgio, Cutini, Ilaria, Bonetti, Maria Ida, Masciulli, Arianna, Audisio, Ernesta, Ferrero, Dario, Pavoni, Chiara, Scattolin, Anna Maria, Bosi, Alberto, Rambaldi, Alessandro, Bassan, Renato
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6988394/
https://ncbi.nlm.nih.gov/pubmed/31978214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000406
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados